Meno-Phase
Meno-Phase, licence 80059778: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80059778
- Status
- Inactive licence
- Licence date
- 10 April 2015
- Revision date
- 24 August 2020
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1000 milligramme Potency : 0.5 % Agnuside | 100.0 milligramme | Not calculated |
| Taraxacum officinale Source : Taraxacum officinale - Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 milligramme | 25.0 milligramme | Not calculated |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 milligramme Potency : 2.5 % Triterpene glycosides | 200.0 milligramme | Not calculated |
| Dioscorea villosa Source : Dioscorea villosa - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 milligramme Potency : 6.0 % Diosgenin | 100.0 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 10 g Potency : 12.4 mg ÉAI Isoflavones | 50.0 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Potency : 40.0 % Isoflavones | Not specified | Not calculated |
Non-medicinal ingredients
Croscarmellose sodium, Dextrine, Maltodextrine, Dioxyde de silicium, Microcrystalline cellulose, Stéarate de magnésium, Phosphate de calcium, monobasique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 2.0 Comprimé | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the pain associated with menstruation. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help relieve symptoms associated with menopause. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80059778
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.